entertainment -WSS

entertainment

author：leisure time 2025-08-28 08:40:54 - browse：6872

STAT's Megan Molteni speaks with Feng Zhang in New York on March 21, 2024 — Scientist Feng Zhang, right, is interviewed by reporter Megan Molteni at STAT's Breakthrough Summit East. STAT

When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas Medicine seemed like the pacesetter. It locked up some of the crucial IP, and had behind it the pioneering scientist Feng Zhang of the Broad Institute as one of its founders.

But now, a decade later, Editas is seen as lagging behind its peers. CRISPR Therapeutics, in partnership with Vertex Pharmaceuticals, won the race to get the first CRISPR-based medicine across the finish line. Intellia Therapeutics was the first to show that CRISPR editing could be performed inside the body. Editas, meanwhile, has seen a revolving door among its executives.

So what happened?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

leisure time

WSS

Adopting new red light myopia treatments may be short

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Biden targets hefty hospital 'facility fees' that often surprise patients

Updated Covid vaccine has 54% effectiveness, new study suggests

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Biden targets hefty hospital 'facility fees' that often surprise patients

explore

entertainment

knowledge

Walensky prepares to leave CDC — and Congress — behind

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Medicare proposal to cover medical devices draws a mixed reaction

White House announces new plan to address the growing threat of xylazine in overdose crisis

After affirmative action ruling, medical educators look to 'holistic review'

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

In Memoriam: Notable people who died in 2023

Judge agrees to delay next hearing in Trump classified documents case

Medicare proposal to cover medical devices draws a mixed reaction

Readout LOUD: Venture capital, Gilead, and more M&A

leisure time

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Recent heat wave in the Mediterranean caused by climate change: Study

The Biogen Aduhelm mess could happen again

Readout LOUD: Venture capital, Gilead, and more M&A

The Biogen Aduhelm mess could happen again

What’s missing from the debate over nursing home staff minimums

hotspot

hotspot

leisure time

explore